Apligraf

The printable version is no longer supported and may have rendering errors. Please update your browser bookmarks and please use the default browser print function instead.

Apligraf is a synthetic skin created from harvested foreskins.^[1] It is FDA approved,^[2] and it is made and sold by Organogenesis, a corporation based in Canton, MA. Novartis Pharmaceuticals Corp. has global marketing rights to Apligraf.

Apligraph Oral

Organogenesis is presently seeking FDA approval for Apligraph Oral, a foreskin-derived product for the "treatment of surgically treated gingival and alveolar mucosal surface defects in adults."^[3]

References

↑ Apligraf: How Is It Made?, Organogenesis. Retrieved 6 March 2011.
Quote: Human keratinocytes and fibroblasts are derived from neonatal foreskins
↑ Apligraf, Organogenesis. Retrieved 6 March 2011.
Quote: Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).
↑ (17 November 2011)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.

[1] Apligraf: How Is It Made?, Organogenesis. Retrieved 6 March 2011.
Quote: Human keratinocytes and fibroblasts are derived from neonatal foreskins

[2] Apligraf, Organogenesis. Retrieved 6 March 2011.
Quote: Apligraf® is the first bio-engineered cell based product to receive FDA approval (in 1998).

[3] (17 November 2011)."November 17, 2011: Cellular, Tissue and Gene Therapies Advisory Committee Meeting: Transcript", FDA. Retrieved 20 December 2011.

[1]

[2]

[3]

Apligraf

Apligraph Oral

References

Navigation menu

Search